New Research on Treatment for Ovarian Cancer: More Women Are Now Eligible to Receive a PARP Inhibitor

New research shows that ovarian cancers without BRCA mutations—as well as cancers that haven't responded to chemotherapy in the past—may benefit from PARP inhibitors, too.

Published Jul 5, 2019

NOW
PLAYING
In Italy, Cancer Patients Are Facing Limited Options
NOW
PLAYING
Remembering the Incredible Life of Emily Garnett -- A Champion for Metastatic Breast Cancer Awareness
NOW
PLAYING
L.A. Neighborhood Throws Social Distancing Parade for Teen on Her Last Day of Chemo
NOW
PLAYING
Keeping Your Immune System Healthy During the COVID-19 Pandemic
NOW
PLAYING
Is a Cancer Boom Coming? Coronavirus Stops Mammograms, Colonoscopies, and PSA Tests
NOW
PLAYING
Dramatic Improvement in Melanoma Survival Rates-- The Treatment Revolution is Working
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.